Sodium-Glucose Cotransporter 2 Inhibitors: Mechanisms of Action and Various Effects / 임상당뇨병
Journal of Korean Diabetes
;
: 74-80, 2019.
Artigo
em Coreano
| WPRIM
| ID: wpr-761481
ABSTRACT
The basic action mechanism of sodium-glucose cotransporter 2 (SGLT2) inhibitor is to lower the glucose burden by excreting the glucose filtered by the kidney into the urine. Although SGLT2 inhibitors are primarily indicated as glucose-lowering agents, they have a broad range of effects on renal function and plasma volume homeostasis, as well as on adiposity and energy metabolism across the entire body. That might be why SGLT2 inhibition causes spill-over of sodium and glucose beyond the proximal tubule, triggering dynamic and reversible realignment of energy metabolism, renal filtration, and plasma volume. A better understanding of SGLT2 inhibition in the kidney and the entire body will lead to more benefits in people with and without diabetes.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Volume Plasmático
/
Sódio
/
Mecanismos Moleculares de Ação Farmacológica
/
Diabetes Mellitus
/
Metabolismo Energético
/
Adiposidade
/
Filtração
/
Glucose
/
Homeostase
/
Rim
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS